Jinsong Liu

Dr. Jinsong Liu is a professor with tenure in the Department of Pathology at The University of Texas M. D. Anderson Cancer Center.  He received his medical education in China and came to the United States through the China–the United States Biochemistry Examination Application program (CUSBEA). He received his Ph.D. degree in Biochemistry from Case Western Reserve University in 1991. He completed his postdoctoral training at the University of Michigan and his pathology residency and surgical pathology fellowship training at New York University School of Medicine from 1994 to 1999. He is certified by American Board of Anatomic Pathology. He joined the faculty in the Department of Pathology at The University of Texas M. D. Anderson Cancer in 1999 as an Assistant Professor and was promoted to Associate Professor in 2004 and professor in 2009 with tenure.

Dr. Liu is an active member of a world renowned diagnostic team focusing on gynecologic malignancies and laboratory investigator at M. D. Anderson Cancer Center. Dr. Liu is an internationally recognized for his expertise in diagnosis of gynecologic tumors and research achievements in ovarian cancer. His research has focused on the mechanisms of epithelial tumorigenesis, inflammation, tumor microenvironment. Recently, his group shows first time that polyploidy giant cancer cells (PGCCs) can be the cancer origin and relapse. Dr. Liu’s research has been continuously funded by multiple grants from different funding agencies. Dr. Liu has co-authored 270 peer reviewed original publications reviews in many prestigious scientific journals. His work has been cited >15,000 time with H-index 68.

He has given multiple lectures at national and international meetings and more than 30 institutions in US, Europe, and China. Dr. Liu has been an editorial member of several reputable journals. He received most prestigious Lin Qiaozhi Cup Award in 2018 by Chinese Gynecologic Society and is only first and only pathologist in North American received this award.